Technology | Cardiovascular Ultrasound | March 20, 2017

Toshiba Medical’s Aplio i900 Cardiovascular Ultrasound Receives FDA Clearance

Premium system delivers fast, high-quality images for better diagnostic confidence

Toshiba Medical, Aplio i900 cardiovascular ultrasound, FDA clearance, ACC 2017, RSNA 2017

March 20, 2017 — Cardiologists can now access the advanced ultrasound imaging technology needed for fast and confident diagnoses with Toshiba Medical’s Aplio i900. The newly U.S. Food and Drug Administration (FDA)-cleared system is the latest addition to the premium Aplio i-series ultrasound platform with excellent imaging clarity and definition.

The Aplio i900 brings ultra-premium cardiac imaging to an everyday clinical setting, offering healthcare facilities a more cost-effective, less invasive and safer solution than other radiation-emitting modalities. The system offers innovative features that allow clinicians to quickly and easily assess myocardial function, or to quantify complex valvular lesions with greater depth and detail.

Ideally suited for contrast, fetal, pediatric, stress echo and transesophageal echocardiography imaging, according to Toshiba, the Aplio i900 delivers extreme processing power that helps healthcare providers see more in their ultrasound exams due to thinner beam slices and more return information in each image. A new beam-forming technology, iBeam, optimizes efficiency of the beam, increasing penetration, spatial resolution and contrast resolution. Boosting productivity during exams, the Aplio i900 provides intuitive ergonomics with iSense and touch control screens, and real-time quick scan makes automatic image adjustments without pushing a button.

Toshiba Medical showcased the Aplio i900 at this year’s American College of Cardiology (ACC) 2017 annual meeting in Washington, D.C., March 17–19, 2017.

For more information: www.medical.toshiba.com

Related Content

Toshiba, Aplio i-series, MSK, musculoskeletal ultrasound, RSNA 2017
Technology | Ultrasound Imaging | March 29, 2017
March 29, 2017 — Toshiba Medical recently announced the launch of its new premium Aplio i-series...
prenatal ultrasound, decreased bone density, rabbit study, Pertanika Journal of Science & Technology
News | Ultrasound Imaging | March 28, 2017
March 28, 2017 — Young rabbits exposed to...
iCAD, PowerLook Tomo Detection, computer-aided detection software, CAD, digital breast tomosynthesis, DBT, RSNA 2017
Technology | Computer-Aided Detection Software | March 27, 2017
March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S.
Medsquare, VirtualDose CT module, organ dose calculation, DACS Radiation Dose Monitor, RDM
Technology | Radiation Dose Management | March 24, 2017
Medsquare announced the integration of the organ dose module VirtualDose CT into its DACS (dose archive and...
GE Healthcare, Senographe Pristina mammography system, launch, RSNA 2017, patient comfort
News | Mammography | March 24, 2017
GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening...
ContextVision, 3-D ultrasound, SkeletalView, patent, fetal skeleton viewing, RSNA 2017
News | Advanced Visualization | March 23, 2017
ContextVision recently received a patent approval on a new skeletal visualization technology for 3-D ultrasound.
Sectra, enterprise imaging, RIS, PACS, VNA, Danderyd Hospital, Sweden, RSNA 2017
News | Enterprise Imaging | March 23, 2017
March 23, 2017 — Swedish healthcare provider Danderyd Hospital AB has signed a five-year contract with Sectra for the
Karmanos Cancer Institute, UroNav Fusion Biopsy System, prostate cancer
News | Biopsy Systems | March 23, 2017
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroN
News | Prostate Cancer | March 22, 2017
Profound Medical Corp. announced that it has successfully completed the first sale of a TULSA-PRO system in Finland to...
Overlay Init